We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$13.5B
AUM Growth
-$537M
Cap. Flow
-$203M
Cap. Flow %
-1.51%
Top 10 Hldgs %
19.68%
Holding
385
New
13
Increased
113
Reduced
185
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$46.3M
2
QCOM icon
Qualcomm
QCOM
+$36.9M
3
ATKR icon
Atkore
ATKR
+$27.5M
4
WTRG icon
Essential Utilities
WTRG
+$26.1M
5
HALO icon
Halozyme
HALO
+$19.4M

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$43.2M
2
CPE
Callon Petroleum Company
CPE
+$35.4M
3
UMBF icon
UMB Financial
UMBF
+$31M
4
SLB icon
SLB Ltd
SLB
+$30.8M
5
JPM icon
JPMorgan Chase
JPM
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 24.52%
2 Financials 14.32%
3 Healthcare 14.05%
4 Industrials 13.81%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
276
Walmart Inc
WMT
$858B
$1.04M 0.01%
15,366
+69
+0.5% +$4.34K
STT icon
277
State Street
STT
$50.9B
$1.02M 0.01%
13,836
-250
-2% -$18.6K
PPG icon
278
PPG Industries
PPG
$23.3B
$1.02M 0.01%
8,120
-1,825
-18% -$242K
DIS icon
279
Walt Disney
DIS
$184B
$966K 0.01%
9,731
-425
-4% -$45.8K
BLK icon
280
Blackrock
BLK
$164B
$963K 0.01%
1,223
MCK icon
281
McKesson
MCK
$105B
$961K 0.01%
1,646
FISV
282
Fiserv Inc
FISV
$26.6B
$891K 0.01%
5,975
-43
-0.7% -$6.51K
TSCO icon
283
Tractor Supply
TSCO
$17.2B
$879K 0.01%
16,270
-625
-4% -$33.6K
BSX icon
284
Boston Scientific
BSX
$63.6B
$861K 0.01%
11,181
GE icon
285
GE Aerospace
GE
$319B
$857K 0.01%
5,389
-1,480
-22% -$236K
ETN icon
286
Eaton
ETN
$152B
$826K 0.01%
2,634
-20
-0.8% -$6.46K
IWB icon
287
iShares Russell 1000 ETF
IWB
$48.4B
$805K 0.01%
2,705
WFC icon
288
Wells Fargo
WFC
$271B
$803K 0.01%
13,515
IWM icon
289
iShares Russell 2000 ETF
IWM
$76.9B
$799K 0.01%
3,937
-631
-14% -$128K
LHX icon
290
L3Harris
LHX
$46.5B
$798K 0.01%
3,555
+25
+0.7% +$5.4K
CBT icon
291
Cabot Corp
CBT
$4.09B
$790K 0.01%
8,600
-200
-2% -$19.4K
NVO
292
Novo Nordisk
NVO
$188B
$766K 0.01%
5,366
VCIT icon
293
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$68.7B
$761K 0.01%
9,527
-210
-2% -$16.7K
VIG icon
294
Vanguard Dividend Appreciation ETF
VIG
$111B
$752K 0.01%
4,121
-51
-1% -$9.18K
EL icon
295
Estee Lauder
EL
$34.8B
$749K 0.01%
7,043
-1,855
-21% -$243K
DFAC icon
296
Dimensional US Core Equity 2 ETF
DFAC
$48.5B
$694K 0.01%
21,537
BF.B icon
297
Brown-Forman Class B
BF.B
$12B
$690K 0.01%
15,967
+85
+0.5% +$3.99K
NOC icon
298
Northrop Grumman
NOC
$75.5B
$684K 0.01%
1,568
-38
-2% -$17.4K
TSLA icon
299
Tesla
TSLA
$1.41T
$682K 0.01%
3,448
-2,030
-37% -$355K
CLX icon
300
Clorox
CLX
$10.5B
$674K 0.01%
4,942
-765
-13% -$106K

Similar funds

Boston Trust Walden's Q2 2024 Portfolio in Review

As of Q2 2024, Boston Trust Walden held 385 positions worth $13.5B, down 3.8% from $14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2024 filing shows 13 new, 113 increased, 185 reduced and 7 closed positions. Its largest new stake was Atkore: 172,729 shares worth $23.3M. The largest sale was Medpace, an estimated $43.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2024 buy was Atkore: 172,729 shares worth $23.3M.
  • Boston Trust Walden added most to NVIDIA in Q2 2024, an estimated $46.3M increase.
  • Boston Trust Walden's biggest Q2 2024 reduction was Medpace, cutting an estimated $43.2M.
  • Boston Trust Walden fully exited Callon Petroleum Company in Q2 2024, selling an estimated $35.4M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $13.5B portfolio in Q2 2024.
  • Boston Trust Walden opened 13 new positions and closed 7 in Q2 2024.
  • Boston Trust Walden's portfolio value fell 3.8% quarter-over-quarter to $13.5B.

Based on Boston Trust Walden's 13F filing for Q2 2024, filed 19 Jul 2024.